Rapid Micro Biosystems Inc (RPID) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) has a cash flow conversion efficiency ratio of -0.738x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.06 Million) by net assets ($20.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Rapid Micro Biosystems Inc balance sheet independence to measure how much of total assets are equity-financed.
Rapid Micro Biosystems Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Rapid Micro Biosystems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore RPID long-term investment intensity to see how much of total assets are deployed in long-term investments.
Rapid Micro Biosystems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Micro Biosystems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WIZ CORP Inc
KQ:038620
|
0.016x |
|
Tai Tung Communication Co Ltd
TW:8011
|
0.040x |
|
Purit Co. Ltd.
KQ:445180
|
0.022x |
|
Nuveen California Select Tax Free Income Closed Fund
NYSE:NXC
|
-0.014x |
|
Island Pharmaceuticals Ltd
AU:ILA
|
-0.237x |
|
Kaiser Reef Ltd
AU:KAU
|
0.405x |
|
MFS High Yield Municipal Closed Fund
NYSE:CMU
|
0.024x |
|
Collins Co Ltd
TW:2906
|
0.068x |
Annual Cash Flow Conversion Efficiency for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Rapid Micro Biosystems Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see RPID market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $33.21 Million | $-31.06 Million | -0.935x | -59.64% |
| 2024-12-31 | $75.35 Million | $-44.15 Million | -0.586x | -53.36% |
| 2023-12-31 | $117.99 Million | $-45.08 Million | -0.382x | -7.14% |
| 2022-12-31 | $164.17 Million | $-58.55 Million | -0.357x | -43.38% |
| 2021-12-31 | $220.98 Million | $-54.96 Million | -0.249x | +80.08% |
| 2020-12-31 | $24.82 Million | $-31.00 Million | -1.249x | -104.28% |
| 2019-12-31 | $-725.00K | $-21.15 Million | 29.168x | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more